News

Linezolid was introduced by the World Health Organization (WHO) in 2022, as part of the BPaLM regimen, also comprising ...
Research shows that patients with six or more prescriptions for gabapentin, commonly used to treat lower back pain, were 29% more likely to be diagnosed with dementia and 85% more likely to be ...
There are many things we’ve learned from studying the ancient Egyptians. One especially fascinating discovery was evidence of ...
Detailed analysis of TB-related deaths in India, highlighting the need for audits to meet TB elimination goals.
The newly published results of two small clinical trials suggest that two novel antibiotics could provide safer alternatives ...
Antimicrobial resistance not only undermines the efficacy of current treatments but also endangers the entirety of modern ...
PEER-led approaches may significantly improve tuberculosis (TB) screening among people who use drugs (PWUD)—a population at high risk for TB but often overlooked by traditional health systems. Dr ...
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with ...
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...
Two international clinical studies led by PD Dr Norbert Heinrich at the Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich with international partners have shown ...
Post-translational modifications (PTMs) are essential players in regulating protein functions, including stability, localization, and interactions, and they ...